1.
Diabetes: an ounce of prevention is worth a pound of cure
by The Lancet
Lancet (London, England), 05 September 2015, Vol.386(9997), pp.932

2.
GW26-e1430 Fufangxueshuantong ameliorates diabetic cardiomyopathy in rats by attenuating cardic and metabolic dysfunction
by Han, Jing
Journal of the American College of Cardiology, Oct 20, 2015, Vol.66(16), p.C84

3.
GW26-e5354 Suv39h1 Promotes Neointima Formation in Diabetes
by Chen, Jing
Journal of the American College of Cardiology, Oct 20, 2015, Vol.66(16), p.C93

4.
GW26-e4786 Protective effects of naringin on diabetic cardiomyopathy in rats through inhibiting p38MAPK pathway
by Jie, Hai
Journal of the American College of Cardiology, Oct 20, 2015, Vol.66(16), p.C76

5.
GW26-e2947 Is The Benefits Of Enhanced External Counter Pulsation In Patient With Moderate Left Ventricular Dysfunction Independent of Diabetes?
by Subramanian, Ramasamy
Journal of the American College of Cardiology, Oct 20, 2015, Vol.66(16), p.C142

6.
GW26-e3603 Cardiac Fibroblast Contributes to Myocardial Fibrosis in Mice With Diabetes Mellitus-Role of Cardiomyocyte-Fibroblast Interaction
by Song, Jia
Journal of the American College of Cardiology, Oct 20, 2015, p.C14

7.
GW26-e4796 Effect of Naringin on myocardial remodeling by regulating the expression of FABP4, FFA in rats with Diabetes cardiomyopathy
by Mo, Leitong
Journal of the American College of Cardiology, Oct 20, 2015, Vol.66(16), p.C130

8.
Diabetes Mellitus and Clopidogrel Response Variability
by Price, Matthew J
Journal of the American College of Cardiology, 09 September 2014, Vol.64(10), pp.1015-1018

9.
GW26-e3886 A Body Shape Index and Body Roundness Index: Two new body indices to identify diabetes mellitus among rural populations in northeast China
by Chang, Ye
Journal of the American College of Cardiology, Oct 20, 2015, p.C114

10.
Profile: Joslin Diabetes Center, Boston, MA, USA.
by Owens, Brian
Lancet (London, England), September 5, 2015, Vol.386(9997), p.944

11.
The marathon of diabetes.
by Ofri, Danielle
Lancet (London, England), May 23, 2015, Vol.385(9982), pp.2039-2040

12.
Fergus Cameron: getting the big picture in childhood diabetes.
by Kirby, Tony
Lancet (London, England), May 23, 2015, Vol.385(9982), p.2038

13.
Design of potent and selective GPR119 agonists for type II diabetes
by Szewczyk, Jason W
Bioorganic & Medicinal Chemistry Letters, 2011, Vol.21(9), pp.2665-2669

14.
Discovery of a second generation agonist of the orphan G-protein coupled receptor GPR119 with an improved profile
by Semple, Graeme
Bioorganic & Medicinal Chemistry Letters, 15 February 2012, Vol.22(4), pp.1750-1755

15.
Structure-based design of pyridopyrimidinediones as dipeptidyl peptidase IV inhibitors
by Lam, Betty
Bioorganic & Medicinal Chemistry Letters, 01 November 2012, Vol.22(21), pp.6628-6631

16.
The sticking point: diabetic sharps disposal practices in the community.
by Costello, Jennifer
July 2013
Journal of general internal medicine, Vol.28(7), pp.868-869
2013

17.
The size of motoneurons of the gastrocnemius muscle in rats with diabetes.
by Muramatsu, Ken
Neuroscience letters, December 7, 2012, Vol.531(2), pp.109-113

18.
DOR undergoes nucleo‐cytoplasmic shuttling, which involves passage through the nucleolus
by Mauvezin, Caroline
FEBS Letters, 21 September 2012, Vol.586(19), pp.3179-3186

19.
A new class of non-thiazolidinedione, non-carboxylic-acid-based highly selective peroxisome proliferator-activated receptor (PPAR) γ agonists: Design and synthesis of benzylpyrazol...
by Rikimaru, Kentaro
Bioorganic & Medicinal Chemistry, 15 January 2012, Vol.20(2), pp.714-733

20.
Structure–activity relationships and key structural feature of pyridyloxybenzene-acylsulfonamides as new, potent, and selective peroxisome proliferator-activated receptor (PPAR) γ...
by Rikimaru, Kentaro
Bioorganic & Medicinal Chemistry, 15 May 2012, Vol.20(10), pp.3332-3358
